Position in OVID
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$15,923,358
New position
Shares Held
5,919,464
first reported quarter
Ownership
3.03%
of shares outstanding
% of Portfolio
0.61%
of 13F equity value
Holder Rank
#12
of 131 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026BRAIDWELL LP holds $1,531,675,908 across 50 Biotechnology names. OVID ranks #32 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CAI |
Caris Life Sciences, Inc.
|
8,256,032 | $147,122,490 | |
| 2 | EWTX |
Edgewise Therapeutics, Inc.
|
1,996,965 | $81,136,687 | |
| 3 | SYRE |
Spyre Therapeutics, Inc.
|
879,467 | $78,079,080 | |
| 4 | KOD |
Kodiak Sciences Inc.
|
1,787,318 | $69,633,909 | |
| 5 | XENE |
Xenon Pharmaceuticals Inc.
|
1,131,452 | $68,294,442 | |
| 6 | GLUE |
Monte Rosa Therapeutics, Inc.
|
2,451,562 | $59,327,800 | |
| 7 | DNTH |
Dianthus Therapeutics, Inc. /DE/
|
594,562 | $57,957,903 | |
| 8 | GENB |
Generate Biomedicines, Inc.
|
3,283,844 | $55,398,448 |
All Filings in OVID
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $15,923,358 | 5,919,464 | Shares | Sole | 2026-08-14 | |
| No filing history on record for this holder in this stock. | ||||||